Cargando…

Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort

BACKGROUND: We classified non‐demented European Prevention of Alzheimer's Dementia (EPAD) participants through the amyloid/tau/neurodegeneration (ATN) scheme and assessed their neuropsychological and imaging profiles. MATERIALS AND METHODS: From 1500 EPAD participants, 312 were excluded. Cerebr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingala, Silvia, De Boer, Casper, Masselink, Larissa A, Vergari, Ilaria, Lorenzini, Luigi, Blennow, Kaj, Chételat, Gaël, Di Perri, Carol, Ewers, Michael, van der Flier, Wiesje M, Fox, Nick C, Gispert, Juan Domingo, Haller, Sven, Molinuevo, José Luís, Muniz‐Terrera, Graciela, Mutsaerts, Henri JMM, Ritchie, Craig W, Ritchie, Karen, Schmidt, Mark, Schwarz, Adam J, Vermunt, Lisa, Waldman, Adam D, Wardlaw, Joanna, Wink, Alle Meije, Wolz, Robin, Wottschel, Viktor, Scheltens, Philip, Visser, Pieter Jelle, Barkhof, Frederik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359976/ https://www.ncbi.nlm.nih.gov/pubmed/33811742 http://dx.doi.org/10.1002/alz.12292

Ejemplares similares

The Open-Access European Prevention of Alzheimer’s Dementia (EPAD) MRI dataset and processing workflow
por: Lorenzini, Luigi, et al.
Publicado: (2022)

Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia
por: Luigi, Lorenzini, et al.
Publicado: (2022)

Eigenvector centrality dynamics are related to Alzheimer’s disease pathological changes in non-demented individuals
por: Lorenzini, Luigi, et al.
Publicado: (2023)

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings
por: Vermunt, Lisa, et al.
Publicado: (2020)

European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol
por: Solomon, Alina, et al.
Publicado: (2018)

Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s disease and neurodegeneration stratified by sex
por: Cumplido-Mayoral, Irene, et al.
Publicado: (2023)

Mediterranean diet score is associated with greater allocentric processing in the EPAD LCS cohort: A comparative analysis by biogeographical region
por: Gregory, Sarah, et al.
Publicado: (2022)

Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study
por: Calvin, Catherine M., et al.
Publicado: (2020)

Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)
por: Saunders, Tyler S., et al.
Publicado: (2022)

Eigenvector Centrality Dynamics From Resting-State fMRI: Gender and Age Differences in Healthy Subjects
por: Wink, Alle Meije
Publicado: (2019)

Spatial-Temporal Patterns of β-Amyloid Accumulation: A Subtype and Stage Inference Model Analysis
por: Collij, Lyduine E., et al.
Publicado: (2022)

Longitudinal change in ATN biomarkers in cognitively normal individuals
por: Ebenau, Jarith L., et al.
Publicado: (2022)

Multitracer model for staging cortical amyloid deposition using PET imaging
por: Collij, Lyduine E., et al.
Publicado: (2020)

Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship
por: van Loenhoud, Anna Catharina, et al.
Publicado: (2019)

Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
por: ten Kate, Mara, et al.
Publicado: (2018)

BOLD Noise Assumptions in fMRI
por: Wink, Alle Meije, et al.
Publicado: (2006)

Single-Subject Grey Matter Graphs in Alzheimer's Disease
por: Tijms, Betty M., et al.
Publicado: (2013)

Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease
por: Tijms, Betty M., et al.
Publicado: (2013)

Involving research participants in a pan-European research initiative: the EPAD participant panel experience
por: Gregory, S., et al.
Publicado: (2020)

Data-driven haemodynamic response function extraction using Fourier-wavelet regularised deconvolution
por: Wink, Alle Meije, et al.
Publicado: (2008)

ePAD: An Image Annotation and Analysis Platform for Quantitative Imaging
por: Rubin, Daniel L., et al.
Publicado: (2019)

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project
por: Ebenau, Jarith L., et al.
Publicado: (2020)

White matter microstructure disruption in early stage amyloid pathology
por: Collij, Lyduine E., et al.
Publicado: (2021)

Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
por: Lopes Alves, Isadora, et al.
Publicado: (2020)

Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohort
por: Saleh, Rasha N. M., et al.
Publicado: (2023)

Regional associations of white matter hyperintensities and early cortical amyloid pathology
por: Lorenzini, Luigi, et al.
Publicado: (2022)

Exploring the ATN classification system using brain morphology
por: Heinzinger, Nils, et al.
Publicado: (2023)

Age differences in the association between sleep and Alzheimer's disease biomarkers in the EPAD cohort
por: Naismith, Sharon L., et al.
Publicado: (2022)

O011 Associations between sleep and Alzheimer’s disease biomarkers within the EPAD cohort
por: Naismith, S, et al.
Publicado: (2021)

An exploratory clinical study of p38α kinase inhibition in Alzheimer's disease
por: Scheltens, Philip, et al.
Publicado: (2018)

Widespread Disruption of Functional Brain Organization in Early-Onset Alzheimer’s Disease
por: Adriaanse, Sofie M., et al.
Publicado: (2014)

Visual assessment of [(18)F]flutemetamol PET images can detect early amyloid pathology and grade its extent
por: Collij, Lyduine E., et al.
Publicado: (2021)

The value of arterial spin labelling perfusion MRI in brain age prediction
por: Dijsselhof, Mathijs B. J., et al.
Publicado: (2023)

The association of serum uric acid with cognitive impairment and ATN biomarkers
por: Huang, Shan, et al.
Publicado: (2022)

Surgical Outcomes of Myopic Foveoschisis According to the ATN Classification System
por: Fang, Dong, et al.
Publicado: (2022)

ATN profile classification across two independent prospective cohorts
por: Peretti, Débora E., et al.
Publicado: (2023)

Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals
por: Ingala, Silvia, et al.
Publicado: (2021)

VALIDATION OF THE RECENTLY DEVELOPED ATN CLASSIFICATION AND GRADING SYSTEM FOR MYOPIC MACULOPATHY
por: Ruiz-Medrano, Jorge, et al.
Publicado: (2020)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
por: Tan, Meng-Shan, et al.
Publicado: (2020)

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study
por: Scheltens, Philip, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h7smrbtfem11bci3s7bplc41dq